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Abstract
© 2016  WILEY-VCH  Verlag  GmbH  &  Co.  KGaA,  Weinheim3-Benzylmenadiones  are  potent
antimalarial agents that are thought to act through their 3-benzoylmenadione metabolites as
redox cyclers of two essential targets: the NADPH-dependent glutathione reductases (GRs) of
Plasmodium-parasitized  erythrocytes  and  methemoglobin.  Their  physicochemical  properties
were characterized in a coupled assay using both targets and modeled with QSPR predictive
tools built in house. The substitution pattern of the west/east aromatic parts that controls the
oxidant  character  of  the  electrophore  was  highlighted  and  accurately  predicted  by  QSPR
models. The effects centered on the benz(o)yl chain, induced by drug bioactivation, markedly
influenced the oxidant character of the reduced species through a large anodic shift of the
redox potentials that correlated with the redox cycling of both targets in the coupled assay. Our
approach demonstrates that the antimalarial activity of 3-benz(o)ylmenadiones results from a
subtle interplay between bioactivation, fine-tuned redox properties, and interactions with crucial
targets  of  P.  falciparum.  Plasmodione  and  its  analogues  give  emphasis  to  redox
polypharmacology,  which  constitutes  an  innovative  approach  to  antimalarial  therapy.
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